相似文献
1
Strategies to improve medication adherence in patients with schizophrenia: the role of support services.
Neuropsychiatr Dis Treat. 2015 Apr 16;11:1077-90. doi: 10.2147/NDT.S56107. eCollection 2015.
2
Interventions to Improve Medication Adherence in People with Schizophrenia: A Systematic Review.
Patient Prefer Adherence. 2022 Sep 1;16:2431-2449. doi: 10.2147/PPA.S378951. eCollection 2022.
4
The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
JBI Database System Rev Implement Rep. 2015 Jun 12;13(5):244-92. doi: 10.11124/jbisrir-2015-2057.
5
Interventions to improve medication adherence in schizophrenia.
Am J Psychiatry. 2002 Oct;159(10):1653-64. doi: 10.1176/appi.ajp.159.10.1653.
6
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.
Patient Relat Outcome Meas. 2014 Jun 23;5:43-62. doi: 10.2147/PROM.S42735. eCollection 2014.
7
Interventions for enhancing medication adherence.
Cochrane Database Syst Rev. 2008 Apr 16(2):CD000011. doi: 10.1002/14651858.CD000011.pub3.
9
Development and validation of motivational messages to improve prescription medication adherence for patients with chronic health problems.
Patient Educ Couns. 2011 Jun;83(3):375-81. doi: 10.1016/j.pec.2011.04.029. Epub 2011 May 24.
10
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
引用本文的文献
1
Levo-Stepholidine as a Potential Cognitive Enhancer: Insights into Executive Function and Memory Improvements.
Biomedicines. 2024 Nov 25;12(12):2680. doi: 10.3390/biomedicines12122680.
2
Experiences of schizophrenia patients with treatment buddy support during the COVID-19 pandemic.
Health SA. 2024 May 10;29:2428. doi: 10.4102/hsag.v29i0.2428. eCollection 2024.
3
Diabetic Ketoacidosis Associated With Second Generation Antipsychotics: A Case Study and Review of Literature.
Psychiatry Investig. 2024 Feb;21(2):111-122. doi: 10.30773/pi.2023.0301. Epub 2024 Feb 22.
4
Adherence of patients with schizophrenia to hypothyroidism treatment.
Glob Ment Health (Camb). 2023 Dec 5;10:e91. doi: 10.1017/gmh.2023.86. eCollection 2023.
5
Investigating the Effect of Adherence to Antipsychotic Therapy on the Length of Stay and Number of Hospitalizations in Patients with Schizophrenia - A Descriptive Analysis.
Patient Prefer Adherence. 2023 Nov 1;17:2737-2747. doi: 10.2147/PPA.S430083. eCollection 2023.
6
Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders.
Mol Psychiatry. 2023 Sep;28(9):3709-3716. doi: 10.1038/s41380-023-02175-z. Epub 2023 Jul 21.
7
Improving kidney care for people with severe mental health difficulties: a thematic analysis of twenty-two healthcare providers' perspectives.
Front Public Health. 2023 Jun 28;11:1225102. doi: 10.3389/fpubh.2023.1225102. eCollection 2023.
8
Exploring the "Insight Paradox" in Treatment-Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine.
Alpha Psychiatry. 2023 May 1;24(3):102-107. doi: 10.5152/alphapsychiatry.2023.221030. eCollection 2023 May.
9
Paliperidone Palmitate: A Breakthrough Treatment for Schizophrenia? A Review on Patient Adherence Levels, Healthcare Resource Utilization and Costs.
Neuropsychiatr Dis Treat. 2023 Mar 7;19:519-530. doi: 10.2147/NDT.S374696. eCollection 2023.
10
Development of the PREMIUM Computerized Adaptive Testing for Measuring the Quality of Information Delivered to Patients with Severe Mental Illnesses.
J Clin Med. 2022 Nov 11;11(22):6687. doi: 10.3390/jcm11226687.
本文引用的文献
1
Why are the outcomes in patients with schizophrenia so poor?
J Clin Psychiatry. 2014;75 Suppl 2:20-4. doi: 10.4088/JCP.13065su1.05.
2
Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.
J Clin Psychiatry. 2013 Dec;74(12):1249-55. doi: 10.4088/JCP.12m08331.
3
Physical health inequities in people with severe mental illness: identifying initiatives for practice change.
Issues Ment Health Nurs. 2013 Dec;34(12):855-62. doi: 10.3109/01612840.2013.832826.
4
Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial.
BMJ. 2013 Oct 7;347:f5847. doi: 10.1136/bmj.f5847.
5
The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia.
Schizophr Bull. 2013 Nov;39(6):1242-51. doi: 10.1093/schbul/sbt138. Epub 2013 Sep 26.
6
Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
Schizophr Res. 2014 Feb;152(2-3):408-14. doi: 10.1016/j.schres.2013.08.001. Epub 2013 Aug 21.
7
A randomized controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia.
Front Pharmacol. 2013 Aug 9;4:100. doi: 10.3389/fphar.2013.00100. eCollection 2013.
8
Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.
Eur Arch Psychiatry Clin Neurosci. 2014 Feb;264(1):3-28. doi: 10.1007/s00406-013-0436-x. Epub 2013 Aug 13.
9
A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia.
Schizophr Bull. 2013 Sep;39(5):999-1007. doi: 10.1093/schbul/sbs116. Epub 2012 Oct 19.
10
A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia.
Psychiatry Res. 2012 Dec 30;200(2-3):89-95. doi: 10.1016/j.psychres.2012.07.034. Epub 2012 Aug 17.
Zotero 插件